Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.97171
Revised: July 7, 2024
Accepted: July 15, 2024
Published online: March 20, 2025
Processing time: 127 Days and 18.9 Hours
Restless legs syndrome (RLS) is characterized by an urge to move with an un
To assess the epidemiological, clinical, and other aspects of the RLS variant affecting the head.
We conducted a retrospective study of 17 adult patients (> 18 years) who met the RLS criteria and simultaneously experienced RLS-like symptoms in the head.
The median age at which symptoms appeared was 41.6 years. Males and females were equally affected (1.1:1). All 17 patients had uncomfortable sensations in the lower legs. Insomnia or disturbed sleep was the most common comorbidity (n = 16, 88.2%). However, headache was the most common presenting or primary symptom (n = 10, 70.5%). Dizziness or an abnormal sensation in the head was the second most common presenting symptom (5 patients, 29.4%). Other presenting features were leg pain, backache, and generalized body pain. All patients respon
If RLS-related unpleasant sensations and pain are felt in the head, they may be misinterpreted as headache, dizziness, or psychosomatic symptoms. RLS and headaches in a subset of patients may be two phenotypic manifes
Core Tip: Restless head syndrome is an evolving concept. If restless legs syndrome (RLS)-like symptoms are experienced in the head, they may be misinterpreted as headache, dizziness, or psychosomatic symptoms. We suggest that headaches in a subgroup of RLS patients might be part of the RLS spectrum. Such patients may respond to dopaminergic medications.
- Citation: Prakash S, Vadodaria V, Chawda N, Shah CS, Prakash A. Restless head syndrome: A retrospective study. World J Methodol 2025; 15(1): 97171
- URL: https://www.wjgnet.com/2222-0682/full/v15/i1/97171.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i1.97171
Restless legs syndrome (RLS) is a common but often misdiagnosed sensorimotor disorder. It is characterized by an irrepressible urge to move the legs, typically accompanied by unpleasant and uncomfortable sensations in the legs. RLS typically affects the legs, but it can also affect various other body regions, including the arms, abdomen, face, head, neck, and genital area[1,2]. The unpleasant sensations include twitchy, itchy, burning, current-like, ants crawling, creeping, throbbing, tight feeling, prickling, soda-bubbling, restlessness, and pain. About 30% to 50% of RLS patients described pain as a primary component[2]. If RLS-related unpleasant sensations and pain are felt in the head, they may be misinterpreted as dizziness, headache, or psychosomatic symptoms. A few authors have shown that dopamine agonists can relieve headaches and dizziness in RLS patients[3,4]. It is termed restless head syndrome[3,5]. This study focused on 17 patients who not only experienced classic RLS symptoms but also reported pain and other unspecified symptoms in the head. Both RLS and head-related symptoms improved after treatment with dopamine agonists.
We present data on patients who, in addition to typical RLS symptoms, had pain or other non-specific head symptoms and were given a dopamine agonist. The inclusion criteria were as follows: (1) Age > 18 years; (2) patients who met the International Restless Legs Syndrome Study Group (IRLSSG) criteria for RLS; (3) RLS-like symptoms in the head; (4) patients who received dopamine agonists; and (5) a minimum follow-up of more than 4 wk. Our team has been working on RLS for several years. In clinical practice, we noticed that medications started for RLS elicited a response with regard to headache, dizziness, and other nonspecific symptoms of the head. As a departmental policy, we routinely subject every patient with RLS and other head-related symptoms to a thorough clinical history and physical examination. So, all of the data reported here was collected prospectively. All such patients are initially treated with a dopamine agonist alone. The participants were seen in the neurology department of a tertiary hospital between January 2021 and February 2024. The exclusion criteria included: (1) Age < 18 years; (2) patients who did not receive any dopamine agonist; (3) a follow-up of less than 4 wk; (4) patients who did not give consent; and (5) patients having a history of any comorbid conditions, including diabetes mellitus, hypertension, and thyroid disorders. We also excluded the patients who met the migraine criteria. The Institutional Ethics Committee approved the study (SVIEC/ON/MEDI/RP/MARCH/24135). The study was conducted according to the Helsinki Declaration principles.
Continuous data are expressed as the mean ± SD, and dichotomous variables are expressed as frequencies and percentages. Anonymized data not presented herein is available upon reasonable request from the corresponding author on rational request by any qualified researcher.
We found 24 patients who met the inclusion criteria. Seven patients were excluded for the following reasons: Follow-up less than 4 wk (n = 2), those who did not give consent (n = 1), and a history of associated diseases (n = 4; diabetes mellitus-2 patients, hypertension-1, and hypothyroidism-1). Because cases of restless head syndrome are not well documented in the literature, we are providing details about three patients. The clinical characteristics of the remaining 14 patients are summarised in Table 1. Table 2 summarises the clinical, epidemiological, and other features of all 17 cases.
Age/sex | Presenting or chief complain | Duration of illness | Head-related symptoms | Symptoms/sensations of RLS in legs | Arms-back involvement | Insomnia | Lab abnormalities | Treatment | |||
Symptoms | Severe in night | Relief by massage | Dopaminergic drugs | Response | |||||||
56; F | Headache | 15 mo | Tight feeling, stretching | Yes | Yes | Burning, stretching feeling | Arms | Yes | Low ferritin level | Pramipexole 0.250 mg OD | Marked response in 5-6 d |
45; M | Dizziness | 3 years | Worms moving, crawling | Yes | Yes | Pain, crawling | Arms, back | Yes | Ropinirole 0.50 mg OD | Complete response in 2 wk | |
34; F | Headache | 2-3 years | Tight feeling, stretching | Yes | Yes | Tight feeling, stretching | Yes | Pramipexole 0.125 mg OD | Marked response in 2 wk | ||
52; F | Leg pain | 5-6 years | Tight feeling, tearing | Yes | Yes | Tearing | Arms, Back | Yes | Ropinirole 0.50 mg OD | Marked response in 10 d | |
45; M | Dizziness | 2 years | Creeping, floating | Yes | Yes | Throbbing, crawling | Arms | Yes | Pramipexole 0.250 mg OD | Marked response in 7-8 d | |
34; F | Headache | 2-3 years | Tight feeling | Yes | Yes | Creeping, pain | Yes | Ropinirole 0.25 mg OD | Complete response in 2 wk | ||
34; F | Headache, leg pain | 6-7 mo | Tight feeling, stretching | Yes | Yes | Pain, stretching, burning | Arms | Yes | Low serum iron | Levodopa/carbidopa (100/10 mg) | Marked response in 10 d |
25; M | Headache, backache | 5-6 mo | Throbbing, tight feeling | Yes | Yes | Pain, burning Sensation | Arms, back | Yes | low serum iron | Pramipexole 0.250 mg OD | Marked response in 2 wk |
45; F | Headache, backache | 6 mo | Throbbing, stretching | Yes | Yes | Burning, stretching | Yes | Ropinirole 0.50 mg OD | Marked response in 1-2 wk | ||
46; M | Leg pain, headache | 4-5 years | Stretching sensation, tight feeling | Yes | Yes | Pain, stretching, throbbing | Arms, back | Yes | low serum iron | levodopa/carbidopa (100/10 mg) | Marked response in 2 wk |
56; M | Headache, dizziness | 10 mo | Jittery, twitching, numbness | Yes | Yes | Tight feeling, pain, itchy sensation | Arms | Yes | Levodopa/carbidopa (100/10 mg) | Complete response in 1-2 wk | |
32; F | Headache | 4-5 years | Tight feeling, stretching | Yes | Yes | Tearing, ants crawling | Arms, back | Levodopa/carbidopa (100/10 mg) | Marked response in 5-6 d | ||
46; M | Headache, dizziness | 2-3 years | Creeping, stretching | Yes | Yes | Pulling, stretching | Arms, back | Yes | Low vitamin D | Pramipexole 0.250 mg OD | Marked response in 10 d |
54; F | Headache | 6-7 years | Tight feeling, stretching | Yes | Yes | Creeping, pain | Yes | Pramipexole 0.250 mg OD | Complete response in 2 wk |
Parameter | N (17) (%) | |
Age (years) (mean ± SD) | 41.6 (± 9.6) | |
Sex (Male:Female) | 9:8 (1.2:1) | |
Duration of illness (mo) | 53.9 ± 26.2 | |
Presenting features or chief complaints | ||
Headache | 12 (70.5) | |
Dizziness | 5 (29.4) | |
Leg pain | 3 (17.3) | |
Backache | 2 (11.8) | |
Generalized body pain | 2 (11.8) | |
Clinical features | ||
Lower legs discomforts | 17 (100) | |
Headache | 14 (82.3) | |
Arms discomforts | 12 (70.5) | |
Backache | 6 (35.2) | |
Dizziness | 5 (29.4) | |
Generalized body pain | 3 (17.3) | |
Insomnia | 16 (88.2) | |
Met international restless legs syndrome study group criteria | 17 (100) | |
Treatment (dopaminergic agents) | ||
Pramipexole 0.125 to 0.250 mg daily | 8 (47.1) | |
Levodopa/carbidopa (100/10 mg) | 5 (29.4) | |
Ropinirole 0.50 mg daily | 4 (23.5) |
The median age at which symptoms appeared was 41.6 years (range: 32-56 years). Males and females were equally affected (9 female and 8 male cases). All 17 patients had uncomfortable sensations in the lower legs and met the IRLSSG criteria for RLS. Insomnia or disturbed sleep was the most common comorbidity, affecting 16 patients (88.2%). Other common symptoms were headache (14 patients, 82.3%), arm discomforts (12 patients, 70.5%), backache (6 patients, 35.2%), dizziness or unpleasant sensations in the head (5 patients, 35.2%), and generalized body pain (3 patients, 17.3%). In this cohort, headaches accounted for the most common presenting or chief symptom (10 patients, 70.5%). Dizziness or an abnormal sensation in the head was the second most common presenting symptom (5 patients, 29.4%). Other presenting features were leg pain, backache, and generalized body pain.
The patients described their headache or head-related symptoms as a tight feeling, stretching sensation, worms moving, crawling, tearing, creeping, floating, throbbing, jittery, twitching, and numbness. No migranous features, such as nausea, vomiting, photophobia, or phonophobia, were noted with the headaches and other head-related symptoms. The character of headaches fulfilled the International Classification of Headache Disorders, third edition (ICHD-3) criteria of chronic tensiontype headache (CTTH). All patients experienced more intense symptoms in the evening and at night. Headaches and dizziness were also worse at night. All patients experienced relief from lower limb discomfort with leg massages or stretches. Similarly, head massage provided comfort to all patients suffering from headaches, dizziness, or abnormal sensations in the head.
Most of the laboratory workup was unremarkable; three patients had low blood iron levels, one had low ferritin levels, and one had a low vitamin D level. Every patient responded well to dopaminergic treatment. Pramipexole was ad
Case-1: A 31-year-old man had a 5-year history of episodic headaches. In the early years of the illness, headaches occurred about 2-4 times each month. However, the frequency increased progressively over the years, with headaches occurring virtually every day in the prior year. The headache was holocephalic and felt like a tight band across the head. The headache would sometimes feel like it was burning and tearing. The pain mostly fluctuated from mild to moderate in intensity. The symptoms used to be more intense in the evenings and at night. Physical activity did not worsen the headache. He used to feel less or no headaches while engaging in physical activity. The patient never felt nausea, photophobia, or phonophobia. Massaging the pericranial muscles used to relieve headaches.
When questioned, the patient acknowledged having uncomfortable sensations (especially tearing-type pain) in both legs for 4-5 years. Initially, it happened infrequently (4-5 d each month). However, it progressed to every day during the previous 10 mo. The uncomfortable sensation persisted throughout the day, intensifying in the evening and at night. Moving or stretching his legs helped him feel better. In addition, he had been experiencing worsening insomnia for the previous 15 mo. He needed two to four hours to fall asleep. His sleep was not refreshing. The patient visited several doctors regarding his headache. Various preventive drugs were started over the last 2-3 years for the increasing fre
The lower limbs’ symptoms met the IRLSSG criteria for RLS[1]. The IRLS score was 19, indicating a moderate form of the disease. The clinical characteristics of headaches fulfilled the ICHD-3 criteria for chronic tension-type headache[6]. Pramipexole (0.25 mg) was prescribed at bedtime. RLS began to improve within a few days of initiating medication, and a near-complete response was observed within 10 d. In parallel, there was a noticeable decrease in the frequency of headaches, with just 3-4 mild to moderate headache episodes noted over a 6-wk period. The patient was followed up for 15 mo, showing a consistent and nearly complete response. Whenever the drug was stopped or skipped, the RLS, headaches, and insomnia reappeared within a few days. Restarting the medication always resulted in relief from RLS, insomnia, and headaches.
Case-2: A 39-year-old man had a 4-year history of dizziness. Initially, the dizziness was intermittent and short-lasting. However, it gradually worsened, and now it has been present daily for the past 9 mo. He described his dizziness as ‘an abnormal sensation in the head’. When we showed him the list of abnormal sensations described for RLS, the patient mentioned the following sensations in his head: Buzzing, pulling, tight feeling, fullness, floating, and worms moving sensations. Although the abnormal head sensations persisted throughout the day, they were more intense when resting or relaxing, especially in the evening and at night. He could not sleep properly because of the uncomfortable sensations in his head. It takes him two to three hours to fall asleep. He also often woke up in the middle of the night. Massage of the pericranial muscles was used to relieve headache. When questioned, the patient acknowledged the presence of unpleasant sensations in both legs for several years. It was infrequent at first, occurring only 2-4 d each month. But for the previous two years, symptoms have been experienced around 10 to 15 d a month. Similar to the abnormal sensation of the head, the unpleasant sensation of the legs was felt as a combination of a stretching sensation, a tight feeling, and diffuse pain. Walking, massaging, and stretching the legs all helped to reduce or alleviate leg discomfort. The patient used to do some activities at night to get relief from abnormal sensations in the legs and head.
The patient visited several physicians regarding his dizziness and abnormal sensations in the head. He received several provisional diagnoses over 3-4 years: Psychogenic dizziness, vestibular migraine, persistent postural perceptual di
We gave a trial of levodopa/carbidopa (100/10 mg) for RLS. The patient noted a marked improvement in both RLS and dizziness, and the abnormal sensations of the head, within 1-2 wk. The patient had never experienced such relief from any medication for dizziness before. Three months later, the medication was withdrawn. However, the symptoms reappeared after just a few days. Restarting the medication provided complete relief from RLS and dizziness. During a 9-mo follow-up period, the patient demonstrated a consistent and complete response.
Case-3: A 42-year-old woman reported diffuse body pain, including headaches, for about 8 years. The pain initially only affected the legs. The pain spread over time and began to affect additional areas of the body. Although the patient was still experiencing more discomfort in her legs, she was also experiencing pain in her head, neck, arms, scapular area, buttocks, and upper and lower back. For the preceding 2 to 3 years, she had pain all over her body, with the exception of the abdomen and chest.
Initially, the pain was infrequent, 4-5 d in a month. The frequency gradually increased over the years. The pain had been present most of the time for 2 to 3 years. It was felt as a combination of a constant dull ache, a stretching feeling, and a burning sensation. The back pain was frequently accompanied by itchy sensations. The pain was deep-seated and restricted to the muscles. She denied pain in the joints. The diffuse body pain and headaches were mild at the beginning of the day, increased towards the end of the afternoon, and became more severe at night. She used to have less discomfort while engaging in activities. The pain prevented her from falling asleep. In addition, she would often wake up in the middle of the night. Because of the pain and poor sleep, she used to experience anxiety during the night. Her spouse attested to her restlessness during sleep, exhibiting frequent tossing, twisting, and excessive turning in bed. Sometimes, to relieve her discomfort at night, she had to get out of bed to stretch her limbs or take a walk. She used to stretch her back to get relief from back pain and itching.
Along with her generalized body pain and abnormal sensations in the body, she also reported experiencing headaches and dizziness. She described headaches and dizziness as part of her generalized body pain. Headaches and dizziness were felt as a combination of a stretching sensation, a tight feeling, a floating sensation, and diffuse pain. Similar to the abnormal sensation of the legs and back, headache and dizziness were more severe towards the end of the afternoon and at night. Massage of pericranial muscles was used to relieve headache.
The patient visited several physicians over eight years, including rheumatologists, neurologists, and psychiatrists. She received several diagnoses, including fibromyalgia, vitamin D deficiency, somatic symptom disorder, sleep disorders, and other psychiatric disorders. The patient got a variety of drug regimens (antidepressants, anxiolytics, and multivitamins) and strategies for her illness, including cognitive behavioral therapy. She received duloxetine, amitriptyline, milnacipran, pregabalin, gabapentin, fluoxetine, venlafaxine, ibuprofen, naproxen, indomethacin, and multivitamins. A few of them, especially pregabalin and gabapentin, had some effects on pain. However, none of the therapies had any persistent effects. Physical, rheumatological, and neurological examinations were essentially normal. The patient had undergone numerous investigations over the years. Hematologic and biochemical investigations were unremarkable except for low serum iron (34 mcg/dL). A non-contrast MRI scan of the head and spine showed no abnormalities. EMG and nerve conduction studies were normal.
The lower limbs’ symptoms met the IRLSSG criteria for RLS. Pramipexole was started at a dose of 0.125 mg at bedtime. We advised the patient to increase the dose by 0.125 mg every 3 d to 0.5 mg daily. The patient noted a response on the first day of treatment. The response was observed not only in the leg pain, but also in backache, neck pain, and headache. Her sleep pattern also improved. The generalized body aches almost completely disappeared after 10 d of therapy. Sleep patterns also returned to normal, and she could fall asleep in 10-20 min. The patient had never experienced this kind of response from a medication before. We attempted to discontinue the medication after 5 mo. However, it resulted in the reappearance of body pain, headache, dizziness, and insomnia. The reintroduction of pramipexole again produced a complete response. We followed the patient for about 3 years. We made several attempts to discontinue the drug. The longest remission period without medication was 6 wk. Resuming the treatment resulted in a complete response on all occasions.
RLS typically affects the legs; however, it can affect other regions of the body[7]. About 35%-50% of patients with RLS may have symptoms in the arm[3]. If RLS symptoms get more severe, they may begin to affect other body parts, such as the trunk, abdomen, face, genitals, oral cavity, and head. The gastrointestinal tract and bladder may also be involved. Apart from the arm, isolated involvement in other areas is uncommon, and only a few cases have been reported. Legs are typically affected in such cases and are more severely affected than other body parts. Involvement in the legs occurs several years before involvement in the other body parts[7,8].
The IRLSSG diagnostic criteria (2014) for RLS include four essential criteria: (1) Urge to move with unpleasant sensations in the legs; (2) worse during rest or inactivity; (3) relief by movement or activity; (4) worse in the evening or at night; and (5) not due to another condition[1]. Our patients’ lower limb symptoms met the IRLSSG diagnostic criteria for RLS. However, it is difficult to prove if accompanying headaches, dizziness or other head-related symptoms, back pain, and generalized body pain were part of the RLS spectrum. The urge to move is the central feature of the RLS criteria. The criteria are largely aimed for symptoms in the lower limbs. It is easy to exhibit the urge to move in the legs. However, it is difficult to prove the “urge to move” when RLS affects other body areas, particularly the head, neck, face, and back. A worsening of symptoms in the evening or at night might be an indirect sign of RLS in that body part. Relief by movement or massage of the affected body part may be another indirect sign of RLS in that body area. Headache, dizziness, other head-related symptoms, back pain, and generalized body pain were more intense in the evening and at night. Additionally, symptoms improved following a massage of the head and other affected body regions. Furthermore, administering dopamine agonists relieved these symptoms. We are confident that accompanying headaches, dizziness or other head-related symptoms, back pain, and generalized body pain are all part of the RLS spectrum. Our cases were unique in that head and back symptoms were prominent, with headache, dizziness, back pain, and generalized body pain being the presenting or primary complaints of the patients.
Lower limb symptoms are the primary clinical features of RLS. However, patients frequently seek medical attention primarily because of disturbed sleep[2]. Patients with RLS often delay seeking medical attention for many years. Moreover, even when they seek medical attention, an accurate diagnosis sometimes takes a decade or more. It may be due to patients’ failure to disclose their clinical features to their physicians[9]. In one study, leg symptoms were reported to physicians by just 32% of individuals with moderate-to-severe RLS[10]. Therefore, diagnosing atypical cases affecting areas other than the legs may be exceedingly challenging. Karroum and colleagues conducted a topographic localization of RLS sensations[11]. All individuals reported RLS symptoms in the legs. About 57% of patients felt symptoms in the arms. The trunk (chest, abdomen, and back) and the head were affected in 9% and 5% of patients, respectively. In two patients, the symptoms spread to the whole body. RLS has several variants, depending on the region of involvement: Restless arm syndrome, restless abdomen syndrome, restless mouth syndrome, restless genital syndrome, restless bladder syndrome, restless bowel syndrome, and restless back syndrome[7,8]. These variants may be the primary or only symptom in a subset of patients with RLS.
The symptoms described in RLS patients are twitchy, itchy, burning, current-like, ants crawling, creeping, throbbing, tight feeling, prickling, soda-bubbling, restlessness, pain, and several other non-specific features[2]. If unpleasant sensations and pain are felt in the head, they may be misinterpreted as dizziness, headache, or psychosomatic symptoms. Even a typical case of RLS affecting the legs is misinterpreted as a psychogenic condition[9]. Therefore, physicians are more likely to diagnose RLS variants affecting atypical areas as a psychotic disorder. In 2020, Prakash and Prakash reported two cases of RLS associated with CTTH. Both RLS and CTTH improved after receiving levodopa. The authors hypothesized that headaches may be a part of the RLS symptom complex in a subgroup of patients[3]. They used the term ‘restless head syndrome or cephalic variant of RLS’ to describe such patients. In 2022, Balgetir and colleagues documented 22 such head-related RLS symptoms, which they also termed restless head syndrome[5]. Recently, Prakash and colleagues reported two cases of RLS accompanied with chronic dizziness[4]. Both the dizziness and RLS were resolved with levodopa or dopamine agonist therapy. The authors speculated that dizziness could be a component of the RLS symptom complex.
In our cohort of 17 patients, headache was the chief complaint in 12 (70.5%) patients. Two of them also reported dizziness as one of their chief complaints. Three additional patients reported dizziness as their primary complaint. This subset of patients may represent restless head syndrome. In addition to headaches, backaches were also the primary complaint in two patients. There have also been reports of restless back as the initial symptom of RLS[12,13]. Generalized body pain was the primary complaint of two patients. A few authors have reported generalized body pain in a few patients with RLS[11]. We hypothesize that generalized body pain due to RLS may be termed ‘restless body syndrome’.
Although RLS typically affects the legs, it appears that RLS might affect any body area. RLS is most likely caused by an interaction between impaired dopaminergic neurotransmission in the subcortex of the brain and systemic or brain iron deficiency[14]. The pathophysiology of RLS suggests that it may also affect other body regions, either with or without leg involvement. RLS-related unpleasant sensations include pain. Dopaminergic fibres modulate pain perception and analgesia. Impaired dopaminergic transmission is associated with several painful conditions[15]. RLS is associated with a number of comorbid conditions, including several painful conditions[16]. The associations of RLS have been noted with fibromyalgia, growing pain, chronic back pain, tension-type headache, and migraine. A few studies have shown that individuals with fibromyalgia and growing pain have a higher prevalence of RLS[17]. Baykal Şahin et al[18] recently demonstrated a higher prevalence of RLS in patients with chronic low back pain. Several studies have revealed that people with RLS have a greater lifetime prevalence of migraine than controls[19]. A few open-label studies have shown that dopaminergic treatment can simultaneously alleviate both RLS and migraine[20]. A few studies have also observed a correlation between RLS and TTH. In a nationwide population-based retrospective cohort analysis, Yang et al[21] had shown that patients with TTH had a higher risk of RLS. In another population-based study, Chung et al[22] similarly showed a higher prevalence of RLS in TTH patients.
The link between RLS and various painful disorders raises several questions. Are the diagnoses incorrect? Does having one painful condition increase the likelihood of having another? Are these painful disorders part of the same disease spectrum? Walters and colleagues suggest that RLS and growing pains may be different phenotypic expressions of the same disorder[23]. A similar hypothesis could be suggested for headache disorders, especially for TTH. TTH’s clinical semiology matches the symptoms described for RLS in the legs. Therefore, RLS and TTH in a subset of patients may be two phenotypic manifestations of the same disorder. As mentioned earlier, RLS affects almost all body parts, including visceral organs. Therefore, we hypothesize that RLS could be a generalized disorder, and there may be generalized pain, including headache.
This retrospective study has several limitations. This is a case series, so there is the possibility of unrecognized selection bias. The treatments were not standardized for these patients. We cannot rule out the possibility of secondary causes in these patients, as a comprehensive evaluation for secondary RLS and other associated symptoms was not conducted.
Although RLS typically affects the legs, it appears that RLS might affect any body area, including the head. If RLS-related unpleasant sensations and pain are felt in the head, they may be misinterpreted as headache, dizziness, or psychosomatic symptoms. RLS and TTH in a subset of patients may be two phenotypic manifestations of the same disorder. We propose that headaches in a subgroup of RLS patients might be part of the RLS spectrum. A correct diagnosis is critical, as patients will respond to dopaminergic drugs.
1. | Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB; International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014;15:860-873. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 844] [Cited by in F6Publishing: 941] [Article Influence: 94.1] [Reference Citation Analysis (1)] |
2. | Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2100] [Cited by in F6Publishing: 2038] [Article Influence: 101.9] [Reference Citation Analysis (1)] |
3. | Prakash S, Prakash A. Dopa responsive headache: Restless head syndrome or a cephalic variant of restless legs syndrome? J Family Med Prim Care. 2020;9:4431-4433. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis (0)] |
4. | Prakash S, Patel H, Shah CS, Prakash A. Chronic dizziness in restless legs syndrome (RLS) patients responsive to levodopa or dopamine agonists. BMJ Case Rep. 2024;17. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
5. | Balgetir F, Gönen M, Berilgen A, Aytaç E, Demir CF, Müngen B. Restless legs syndrome affecting the head region: "restless head syndrome". Neurol Sci. 2022;43:2565-2570. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Reference Citation Analysis (0)] |
6. | Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5927] [Cited by in F6Publishing: 5156] [Article Influence: 859.3] [Reference Citation Analysis (0)] |
7. | Turrini A, Raggi A, Calandra-Buonaura G, Martinelli P, Ferri R, Provini F. Not only limbs in atypical restless legs syndrome. Sleep Med Rev. 2018;38:50-55. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis (0)] |
8. | Haghshenas M, Veisani Y, Sahebi A. Restless legs syndrome variants: A systematic review. Heliyon. 2024;10:e28896. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
9. | Walters AS, Hickey K, Maltzman J, Verrico T, Joseph D, Hening W, Wilson V, Chokroverty S. A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey. Neurology. 1996;46:92-95. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 249] [Cited by in F6Publishing: 255] [Article Influence: 9.1] [Reference Citation Analysis (0)] |
10. | Gupta R, Lahan V, Goel D. Restless Legs Syndrome: a common disorder, but rarely diagnosed and barely treated--an Indian experience. Sleep Med. 2012;13:838-841. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis (0)] |
11. | Karroum EG, Leu-Semenescu S, Arnulf I. Topography of the sensations in primary restless legs syndrome. J Neurol Sci. 2012;320:26-31. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis (0)] |
12. | Umehara H, Sumitani S, Ohmori T. Restless legs syndrome with chest and back restlessness as the initial symptom. Psychiatry Clin Neurosci. 2010;64:211. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
13. | Zeng ZF, Liang YR, Chen Y, Jing XN, Peng SD, Tao EX. Chronic back pain cured by low-dose levodopa: is it a variant of restless legs syndrome? J Pain Res. 2018;11:277-279. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
14. | Khan FH, Ahlberg CD, Chow CA, Shah DR, Koo BB. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome. J Neurol. 2017;264:1634-1641. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 8.6] [Reference Citation Analysis (0)] |
15. | Li C, Liu S, Lu X, Tao F. Role of Descending Dopaminergic Pathways in Pain Modulation. Curr Neuropharmacol. 2019;17:1176-1182. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 8.4] [Reference Citation Analysis (0)] |
16. | Trenkwalder C, Allen R, Högl B, Clemens S, Patton S, Schormair B, Winkelmann J. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 2018;17:994-1005. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 106] [Cited by in F6Publishing: 142] [Article Influence: 23.7] [Reference Citation Analysis (0)] |
17. | Stehlik R, Ulfberg J, Hedner J, Grote L. High prevalence of restless legs syndrome among women with multi-site pain: a population-based study in Dalarna, Sweden. Eur J Pain. 2014;18:1402-1409. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis (0)] |
18. | Baykal Şahin H, Karacaoğlu S, Çapkın E, Kara F. Restless legs syndrome in patients with chronic low back pain. Br J Pain. 2023;17:23-27. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
19. | Yang X, Liu B, Yang B, Li S, Wang F, Li K, Hu F, Ren H, Xu Z. Prevalence of restless legs syndrome in individuals with migraine: a systematic review and meta-analysis of observational studies. Neurol Sci. 2018;39:1927-1934. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis (0)] |
20. | Suzuki K, Suzuki S, Miyamoto M, Miyamoto T, Numao A, Watanabe Y, Takashima R, Hirata K. Does pramipexole treatment improve headache in patients with concomitant migraine and restless legs syndrome? Tremor Other Hyperkinet Mov (N Y). 2013;3. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 5] [Reference Citation Analysis (0)] |
21. | Yang FC, Lin TY, Chen HJ, Lee JT, Lin CC, Kao CH. Risk of Restless Legs Syndrome Following Tension-Type Headache: A Nationwide Population-Based Cohort Study. Medicine (Baltimore). 2015;94:e2109. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
22. | Chung PW, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK. Restless legs syndrome and tension-type headache: a population-based study. J Headache Pain. 2017;18:47. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis (0)] |
23. | Walters AS, Gabelia D, Frauscher B. Restless legs syndrome (Willis-Ekbom disease) and growing pains: are they the same thing? A side-by-side comparison of the diagnostic criteria for both and recommendations for future research. Sleep Med. 2013;14:1247-1252. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis (0)] |